ECS update

ECS update

2023/24 season update In 2023/24 ECS Botanics has been actively expanding its facilities and capabilities, demonstrating significant progress in both the cultivation and manufacturing of medicinal cannabis. This includes the continued strategic focus on using organic and regenerative agricultural practices to enhance product quality and environmental sustainability​. Recent achievements and partnerships that ECS Botanics has…

ECS Exclusive: How we pulled off the biggest cross-border pot deal in Aussie history

ECS Exclusive: How we pulled off the biggest cross-border pot deal in Aussie history

On Tuesday, northern Victorian quiet achiever – the medicinal cannabis cultivator and manufacturer ECS Botanics (ASX:ECS) – revealed it secured a stunning five-year, $24 million deal to supply Perth-based MediCann Health with its top (medicinal cannabis dried flower) strain. The deal builds on the existing two-year contract and expects to deliver over four tonnes of dried cannabis flower…

ECS Botanics (ASX:ECS) secures $9.9m cannabis supply agreement

ECS Botanics (ASX:ECS) secures $9.9m cannabis supply agreement

ECS Botanics (ECS) has secured a $9.9 million supply agreement for medicinal cannabis products in Germany. The company entered a binding agreement with German company Ilios Santé GmbH for the supply of medicinal cannabis. Under the contract, ECS will exclusively supply four medicinal cannabis strains to Ilios Sante, with the first supply anticipated once product…

ECS Botanics (ASX:ECS) secures $11.9m to supply medicinal cannabis dried flower in Australia

ECS Botanics (ASX:ECS) secures $11.9m to supply medicinal cannabis dried flower in Australia

ECS Botanics (ECS) has entered two offtake agreements worth a combined more than $11.9 million to supply medicinal cannabis dried flower in Australia. The company announced it will supply Melbourne-based Entoura with Good Manufacturing Practice (GMP) medicinal cannabis dried flower, worth $10.2 million over three years. Entoura supplies and develops high-quality medicinal cannabis products, but also…

ECS Botanics (ASX:ECS) frees up funds with asset sales and new debt facility

ECS Botanics (ASX:ECS) frees up funds with asset sales and new debt facility

Medicinal cannabis company, ECS Botanics (ECS) has launched the sale of two assets and secured a new loan facility. The company agreed to sell its hemp food and wellness business for $250,000 to Ananda Food, with contract completion expected in August upon the finalisation of due diligence. In addition, the company has planned to sell its…

ECS Botanics (ASX:ECS) hands over Tasmanian assets to Blue Buffalo

ECS Botanics (ASX:ECS) hands over Tasmanian assets to Blue Buffalo

ECS Botanics (ECS) has reached financial settlement of its Tasmanian medicinal cannabis business and assets for $3 million. The medicinal cannabis company agreed to sell its subsidiary, TasCo, which holds its Tasmanian operations and farm, to Blue Buffalo for $3 million. On October 24, the company announced to the market it had entered an unconditional…

Medicinal cannabis grower ECS Botanics locks in $24m supply deal with MediCann Health

Medicinal cannabis grower ECS Botanics locks in $24m supply deal with MediCann Health

Shares in ECS Botanics (ASX: ECS) rose by more than 22 per cent this morning after the Victorian medicinal cannabis grower and manufacturer announced its third supply contract win in just over three months, taking the total value of agreements reached since late June to $35.9 million.

Australian Cannabis Companies – top 20
|

Australian Cannabis Companies – top 20

Australian Cannabis Companies 2022 – top 20 list Whether it’s a “gold rush” to secure registration for selling over-the-counter at chemists, proactive outreach to get clinicians on side, or pocket-emptying, long-game research requiring patience and patients at a pharmaceutical level, medicinal cannabis is an industry that attracts all stripes. Against the backdrop of a global…

The US Cannabis Bill. Don’t Get Too Excited About Pot’s Senate Prospects.

The US Cannabis Bill. Don’t Get Too Excited About Pot’s Senate Prospects.

The House of Representatives passed a bill on Friday that would decriminalize marijuana, fueling hopes that the U.S. was one step closer to opening its doors to the cannabis industry at the federal level. The news invigorated cannabis stocks last week, but experts cautioned that marijuana bulls should tamp down their expectations that the measure, called the…

TGA Australia: changes to medical cannabis quality, packaging and labelling requirements

TGA Australia: changes to medical cannabis quality, packaging and labelling requirements

The Therapeutic Goods Administration (TGA) Australia has released details of the much-anticipated changes to medicinal cannabis quality, packaging and labelling requirements which will go into effect on July 1, 2023. Cannabiz exclusively revealed the TGA was considering reforming import quality standards in October 2020. Throughout the consultation period, issues were raised around an uneven playing field, where locally made medicinal…

Cannabis in Australia – being used by tens of thousands as access becomes easier

Cannabis in Australia – being used by tens of thousands as access becomes easier

Cannabis in Australia – It was late 2020 when David decided to talk to his GP about getting a prescription for medicinal cannabis. He’d been diagnosed with fibromyalgia — a condition characterised by widespread pain and tenderness in the body — and had been mostly self-medicating with cannabis he’d bought illegally. “Fibromyalgia is quite debilitating,” he said….

Australian dried cannabis flower high: ECS shares jump on massive Q3 revenue update

Australian dried cannabis flower high: ECS shares jump on massive Q3 revenue update

Growing demand is boosting revenue for medicinal cannabis and hemp company ECS Botanics, which is on track for a massive revenue increase this quarter and a bumper outdoor harvest.   Shares in ECS Botanics (ASX:ECS) rose ~4% to 0.026 cents today on news the company was on track to deliver $2 million in revenue for Q3 FY22. Driven…

Product demand drives revenue growth for ECS Botanics Holdings

Product demand drives revenue growth for ECS Botanics Holdings

Medicinal cannabis and hemp company ECS Botanics Holdings(ASX: ECS) has announced it is on track to deliver another consecutive quarter of revenue growth thanks to sales of its dried flower and cannabis oil products. The company expects to report revenue of about $2 million for the quarter due to end 31 March, which would represent a 39%…

Here’s to you ECS investors: Shares rise as ECS delivers 300% surge in half year revenue

Here’s to you ECS investors: Shares rise as ECS delivers 300% surge in half year revenue

Aussie medicinal cannabis and hemp company group ECS Botanics has recorded a massive jump in revenue amid growing global demand for its unique set of products, here’s to you ECS investors. ECS Botanics (ASX:ECS) has been justly climbing the ASX on Wednesday after the outward looking Aussie cannabis play revealed an impressive 312% increase in first…

Hemp businesses suffering from Facebook advertising rules

Hemp businesses suffering from Facebook advertising rules

Hemp businesses in the US are suffering from Facebook and Instagram’s strict advertising rules despite the product — and its cultivation — being legal in the country for a number of years. Entrepreneur Mike Goose, whose company Let There Be Hemp makes tortilla chips from hemp seeds, has had ads rejected by Facebook since 2019…